netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Topotecan found 8 matches

Open monograph to display formulary status BNF Category
  Cytotoxic Drug Topotecan Malignant disease and immunosuppression - Topoisomerase I inhibitors - 08.01.05
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA183: Topotecan for the treatment of recurrent and stage IVB cervical cancer (08.01.05)
link in drug section NICE TA184: Topotecan for the treatment of relapsed small-cell lung cancer (08.01.05)
link in drug section NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer (08.01.05)
link in drug section NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer (08.01.05)
link in drug section NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer (08.01.05)
link in drug section NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer (08.01.02)
link in drug section NICE TA389: Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer (08.01.03)


 

netFormulary